The present invention relates to novel formulations of tumor-associated peptides binding to human leukocyte antigen class I or II molecules as vaccines for the use in immunotherapeutic methods. A data switch interconnect is coupled to each of the processor cores and configured to pass information among the processor cores. The electrode plate body is attached to each of the collectors located at the outermost side in a laminated direction of the layered cell. Access is permitted or denied according to access policies, which define access in terms of the user groups and information sets.